The aim is to achieve a ceasefire in order to get a massive amount of humanitarian aid into the country for millions of people. However, only one of the two parties to the conflict has accepted the American invitation to the talks; the army is not represented.
“It’s high time for the guns to fall silent,” wrote the US Special Representative for Sudan and head of the talks, Tom Perriello, on the X news service.
More
More
Sudan: everything you need to know about the Geneva negotiations
This content was published on
US-led negotiations on Sudan are underway in Switzerland. Their goal is a ceasefire, but with only one of the warring sides attending, this will prove difficult.
The army (SAF) and the paramilitary militia “Rapid Support Forces” (RSF) have been engaged in a bloody power struggle for around 16 months with no regard for the civilian population.
More than ten million people have been forced to flee, both within their own country and to neighboring countries. More than 25 million people, over half the population, are threatened by acute hunger.
“World is watching”
Representatives of the RSF and delegations from Egypt, Saudi Arabia, the United Arab Emirates and representatives of the African Union and the United Nations travelled to Switzerland for the talks. The exact location of the meeting is being kept secret for security reasons.
“Our US delegation, many international partners technical experts, Sudanese civil society continue to wait for SAF,” Perriello wrote on X. “The world is watching.”
According to Perriello, in the absence of the army, the initial focus will be on technical issues such as how more humanitarian aid can be brought into the country. According to the UN, access is being systematically hindered by high bureaucratic hurdles, among other things. UN convoys with food are often stuck at checkpoints for days. With the onset of the rainy season, roads are becoming increasingly impassable.
Translated from French by DeepL/mga
This news story has been written and carefully fact-checked by an external editorial team. At SWI swissinfo.ch we select the most relevant news for an international audience and use automatic translation tools such as DeepL to translate it into English. Providing you with automatically translated news gives us the time to write more in-depth articles.
If you want to know more about how we work, have a look here, if you want to learn more about how we use technology, click here, and if you have feedback on this news story please write to english@swissinfo.ch.
Popular Stories
More
Climate adaptation
Why Switzerland is among the ten fastest-warming countries in the world
Has your continent reached its peak or is there still potential for economic growth?
Some regions of the world are on an upward trajectory with the promise of a steadily improving future. Where do you live? And in which direction is your region or continent developing?
This content was published on
There is no longer any danger of rockfall or landslide on the roads below the Graubünden village of Brienz, authorities say.
This content was published on
Europe’s biggest freshwater fish tastes better than its reputation, say fishermen in the French-speaking west of Switzerland.
Swiss authorities keep close eye on West Nile fever in Italy
This content was published on
Authorities are keeping a close eye on the situation after the death toll in Italy due to the disease has risen to seven.
Bern biodiversity project brings boost for forest bees
This content was published on
More sunlit areas in forests can boost the number of wild bees – both in overall terms and in terms of species diversity.
Swiss president kicks off National Day celebrations on Rütli meadow
This content was published on
Several hundred people gathered on the Rütli in central Switzerland at midday on Friday to celebrate the national Swiss holiday, before Karin Keller-Sutter addressed the crowd.
US sets deadline for Novartis and other pharma firms to lower prices
This content was published on
US President Donald Trump says he has sent letters to Swiss giant Novartis and other pharma firms calling for lower drug prices in the United States – or face retaliation.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.